Semaglutide Safely Modulates Hypoglycemia Response in Type 2 Diabetes Patients
A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
Abstract
A Randomised, Single-centre, Double-blind, Cross-over Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counter-regulation Compared to Placebo in Subjects With Type 2 Diabetes
NCT ID: NCT02147431
Status: COMPLETED
Sponsor: Nov…